We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




People with Low Vitamin D Live Shorter Lives

By HospiMedica staff writers
Posted on 08 Jul 2008
People who have low levels of vitamin D are more likely to have a shorter life span than people who do not, according to a new study.

Researchers at the Medical University of Graz (Austria) followed 3,258 patients with an average age of 62 for around eight years. More...
The patients had all been referred for a coronary angiography between 1997 and 2000. The researchers analyzed the blood serum levels of two types of vitamin D (25-hydroxyvitamin D and 1,25-dihydroxyvitamin D) in samples taken at enrollment (baseline), compared to their levels at death due to cardiovascular and all causes.

The study results showed that 737 patients (22.6%) died, including 463 deaths from cardiovascular causes during a median follow up of 7.7 years. Patients whose baseline 25-hydroxyvitamin D levels were below the mid-point of the group were at significantly higher risk of death from both cardiovascular and all causes. The effect remained the same when the researchers eliminated cardiovascular risk factors in patients with different levels of physical activity, other illnesses, or coronary artery disease. The figures for 1,25-dihydroxyvitamin D showed similar but slightly weaker effects. Low levels of 25-hydroxyvitamin D also correlated significantly with blood level indicators of inflammation such as C reactive protein (CRP), and oxidative damage to cells. The researchers cautiously suggest that while the study did not prove a causal link, together with evidence from other studies it is possible that vitamin D reduces the risk of atherosclerosis and other cardiovascular problems. The study was published in the June 23, 2008 issue of the Archives of Internal Medicine.

"Based on the findings of this study, a serum 25-hydroxyvitamin D level of 20 nanograms per milliliter or higher may be advised for maintaining general health,” concluded lead author Harald Dobnig, M.D., of the department of internal medicine, and colleagues.


Related Links:
Medical University of Graz

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
ow Frequency Pulse Massager
ET10 L
Pressure Guidewire
SavvyWire
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.